These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21436228)

  • 21. Proximal arterial diameters on CT angiography and digital subtraction angiography correlate both at admission and in the vasospasm period after aneurysmal subarachnoid hemorrhage.
    Kerkeni H; Schatlo B; Dan-Ura H; Remonda L; Muroi C; Diepers M; Fandino J; Fathi AR
    Acta Neurochir Suppl; 2015; 120():171-5. PubMed ID: 25366619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of vasospasm after subarachnoid hemorrhage by use of multislice computed tomographic angiography.
    Otawara Y; Ogasawara K; Ogawa A; Sasaki M; Takahashi K
    Neurosurgery; 2002 Oct; 51(4):939-42; discussion 942-3. PubMed ID: 12234400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffusion-perfusion mismatch in symptomatic vasospasm after subarachnoid hemorrhage.
    Ohtonari T; Kakinuma K; Kito T; Ezuka I; Kanazawa T
    Neurol Med Chir (Tokyo); 2008 Aug; 48(8):331-6; discussion 336. PubMed ID: 18719321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of balloon angioplasty of the anterior cerebral artery for vasospasm treatment after subarachnoid hemorrhage.
    Chaudhry NS; Orning JL; Shakur SF; Amin-Hanjani S; Aletich VA; Charbel FT; Alaraj A
    Interv Neuroradiol; 2017 Aug; 23(4):372-377. PubMed ID: 28335661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
    Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
    Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Symptomatic vasospasm after subarachnoid haemorrhage: assessment of brain damage by diffusion and perfusion-weighted MRI and single-photon emission computed tomography.
    Leclerc X; Fichten A; Gauvrit JY; Riegel B; Steinling M; Lejeune JP; Pruvo JP
    Neuroradiology; 2002 Jul; 44(7):610-6. PubMed ID: 12136364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current management and treatment of cerebral vasospasm complicating SAH.
    Kühn AL; Balami JS; Grunwald IQ
    CNS Neurol Disord Drug Targets; 2013 Mar; 12(2):233-41. PubMed ID: 23394535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endovascular management of cerebral vasospasm.
    McGuinness B; Gandhi D
    Neurosurg Clin N Am; 2010 Apr; 21(2):281-90. PubMed ID: 20380970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage.
    Vajkoczy P; Horn P; Thome C; Munch E; Schmiedek P
    J Neurosurg; 2003 Jun; 98(6):1227-34. PubMed ID: 12816269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repeated Endovascular Treatments in Patients with Recurrent Cerebral Vasospasms After Subarachnoid Hemorrhage: A Worthwhile Strategy?
    Ditz C; Neumann A; Wojak J; Smith E; Gliemroth J; Tronnier V; Küchler J
    World Neurosurg; 2018 Apr; 112():e791-e798. PubMed ID: 29410034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-compliant and compliant balloons for endovascular rescue therapy of cerebral vasospasm after spontaneous subarachnoid haemorrhage: experiences of a single-centre institution with radiological follow-up of the treated vessel segments.
    Neumann A; Küchler J; Ditz C; Krajewski K; Leppert J; Schramm P; Schacht H
    Stroke Vasc Neurol; 2021 Mar; 6(1):16-24. PubMed ID: 32709603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delayed infarction following aneurysmal subarachnoid hemorrhage: Can the role of severe angiographic vasospasm really be dismissed?
    Mortimer AM; Steinfort B; Faulder K; Harrington T
    J Neurointerv Surg; 2016 Aug; 8(8):802-7. PubMed ID: 26186932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Stent Retraction to ReLieve Arterial Cerebral VaSospasm Caused by SAH (Stent-ReLACSS) Using PRELAX the Long-awaited Solution for Treatment of Posthemorrhagic Cerebral Vasospasm? : Treatment of Posthemorrhagic Cerebral Vasospasm with PRESET and PRELAX: Technical Aspects, Efficacy, and Safety Margins in a Case Series.
    Khanafer A; von Gottberg P; Albiña-Palmarola P; Liebig T; Forsting M; Ganslandt O; Henkes H
    Clin Neuroradiol; 2024 Sep; 34(3):649-662. PubMed ID: 38634888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral angioplasty using the Scepter XC dual lumen balloon for the treatment of vasospasm following intracranial aneurysm rupture.
    Heit JJ; Choudhri O; Marks MP; Dodd RL; Do HM
    J Neurointerv Surg; 2015 Jan; 7(1):56-61. PubMed ID: 24385556
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A numerical approach to patient-specific cerebral vasospasm research.
    Ho H; Zhang C; Xie X; Hunter P
    Acta Neurochir Suppl; 2011; 110(Pt 2):157-60. PubMed ID: 21125463
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe cerebral vasospasm caused by non-aneurysmal subarachnoid hemorrhage treatment with transluminal balloon angioplasty.
    Koçak A; Saraç K; Ateş O; Caylỳ SR
    Minim Invasive Neurosurg; 2007 Feb; 50(1):23-6. PubMed ID: 17546539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endovascular treatment: balloon angioplasty versus nimodipine intra-arterial for medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Aburto-Murrieta Y; Marquez-Romero JM; Bonifacio-Delgadillo D; López I; Hernández-Curiel B
    Vasc Endovascular Surg; 2012 Aug; 46(6):460-5. PubMed ID: 22914892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of nimodipine on cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
    Mijailovic M; Lukic S; Laudanovic D; Folic M; Folic N; Jankovic S
    Adv Clin Exp Med; 2013; 22(1):101-9. PubMed ID: 23468268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterisation of DWI-MRI confirmed cerebral infarcts in patients with subarachnoid haemorrhage and their association with MMP-9 levels.
    Lago A; Tembl JI; López-Cuevas R; Vallés J; Santos MT; Moscardó A; Parkhutik V
    Neurol Res; 2015 Aug; 37(8):688-92. PubMed ID: 25916560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.